PCN14 MATCHING-ADJUSTED INDIRECT COMPARISON OF ENTRECTINIB VERSUS CRIZOTINIB IN ROS1 NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS

التفاصيل البيبلوغرافية
العنوان: PCN14 MATCHING-ADJUSTED INDIRECT COMPARISON OF ENTRECTINIB VERSUS CRIZOTINIB IN ROS1 NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
المؤلفون: M. Antoniou, M.K. Bhutani, M. Daigl, A. Aziez, P. Chu
المصدر: Value in Health. 22:S437
بيانات النشر: Elsevier BV, 2019.
سنة النشر: 2019
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Matching (statistics), Crizotinib, business.industry, Health Policy, Public Health, Environmental and Occupational Health, non-small cell lung cancer (NSCLC), Entrectinib, medicine.disease, Indirect comparison, Internal medicine, medicine, ROS1, business, medicine.drug
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dc4f7b2d34305882d4cad5b9dc8d6ef1
https://doi.org/10.1016/j.jval.2019.09.211
حقوق: OPEN
رقم الأكسشن: edsair.doi...........dc4f7b2d34305882d4cad5b9dc8d6ef1
قاعدة البيانات: OpenAIRE